Nov. 22, 2004 — The U.S. Food and Drug Administration (FDA) and Pfizer have notified healthcare professionals via letter of revisions to the safety labeling for medroxyprogesterone acetate (MPA) ...

Thousands of women have filed Depo-Provera lawsuits, saying they developed brain tumors due to their use of the birth control shot. CHESTNUT HILL, MA / ACCESS Newswire / May 20, 2026 / One of the ...

CINCINNATI (WKRC) - A new study allegedly discovered that women using a specific form of birth control had a "significantly higher risk" of developing a brain tumor. A method of birth control used by ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

Feb. 2, 2005 — The U.S. Food and Drug Administration (FDA) approved revisions to drug safety labeling last November, advising healthcare professionals of the following changes: use of ...

The South African Health Products Regulatory Authority (Sahpra) says products with medroxyprogesterone acetate (MPA) are viewed as safe. It has, however, recommended that the product information of ...

Postmenopausal Bleeding Case with Medroxyprogesterone Acetate Therapy Ms. R, a 62-year-old G0 woman presents to the office requesting a refill of her prescription of medroxyprogesterone acetate (MPA; ...

A new study in The American Journal of Pathology, published by Elsevier, reports that medroxyprogesterone acetate (MPA), the active ingredient in the common contraceptive injection Depo-Provera, was ...

TEMPE, Ariz. – The birth control shot Depo Provera offers a convenient alternative for women who don't want to remember to take a daily pill. Ironically, research from Arizona State University has ...